DNA-functionalized quantum dots
DNA-functionalization of quantum dots is the attachment of strands of DNA to the surface of a quantum dot. Although quantum dots with Cd have some cytotoxic release, researchers have functionalized quantum dots for biocompatibility and bound them to DNA in order to combine the advantages of both materials. Quantum dots are commonly used for imaging biological systems in vitro and in vivo in animal studies due to their excellent optical properties when excited by light, while DNA has numerous bioengineering applications, including: genetic engineering, self-assembling nanostructures, protein binding, and biomarkers. The ability to visualize the chemical and biological processes of DNA allows feedback to optimize and learn about these small scale behaviors.
Quantum dots are inorganic nanocrystal semiconductors that behave exceptionally well as fluorophores. In the field of biology, fluorophores are one of the few tools that allow us to peer inside of a live biological system at a cellular level. As a fluorophore, the size of a quantum dot directly reflects the wavelength of light emitted, allowing for a highly tunable color spectrum. Since the size of quantum dots are controllable and an increased size produces an increased wavelength range of emission, researchers are able to paint pictures on the cellular and sub-cellular levels with this technology. The current problem with common CdSe-ZnS quantum dots is that Cd is toxic to cells 
To prevent this problem researches are developing ways to modify the quantum dot surfaces for biocompatibility, in addition to the development of Cd-free quantum dots (“CFQDs”). After a surface modification has been made to limit toxicity, the particle can be further coated with a hydrogel or bioconjugate layer to selectively bind to DNA, which may then be used for cellular or molecular level detection.
Surface Modification Methods
Hydrogel encapsulation of quantum dots
In order to coat the toxic Cadmium ions of the CdSe core, hydrogel layers may be used to coat quantum dots for biocompatibility. The purpose of the outer ZnS shell in this case is to interact with dangling bonds, in addition to maintaining the fluorescent strength of a functional quantum dot fluorophore. Within a hydrogel encapsulation, the ZnSe shell surface may be charged to bind to the hydrophobic interior of a micelle, which then allows the hydrophilic exterior to remain in contact with an aqueous solution (i.e. the human body and most other biological systems). The hydrogel layer works as a simplified intermediary bond for DNA or other organic materials.
Bioconjugation of Quantum Dots
Another surface modification type is bioconjugation. This method uses two biomolecules which are covalently bonded to one another to form a protective shell around the quantum dot. Hydrophobic bioconjugation inhibits the breakdown of the quantum dot structure by sources within the body that may cause degradation. The bioconjugates can be further customized by attaching affinity ligands to the surface of the structure. These ligands allow the quantum dot to bind to various antigens and can be used to specifically target certain cells. This is the driving mechanism for tumor targeting.
Core-shell CdSe-ZnS quantum dots can be protected through bioconjugation, using a coordinating ligand and an amphiphilic polymer. One study used tri-n-octylphosphine oxide (TOPO) as a ligand, and a triblock polymer structure consisting of two hydrophobic segments, and one hydrophilic segment, all with hydrophobic hydrocarbon side chains. The strong hydrophobic interactions between the TOPO and polymer hydrocarbon allow the two layers to “bond” to one another, forming a hydrophobic protection structure. This structure resists degradation via hydrolysis and enzymes, which are common methods of degradation in vivo. This bioconjugation layer protects quantum dot optical properties in a wide range of pH (1-14), salt conditions (0.01-1.0M), and even after 1.0M hydrochloric acid treatment.
Carboxyl groups can be immobilized on the surface of a quantum dot coated in zinc oxide . Single strands of DNA can then be modified with an added amino group in order to covalently bond to the carboxyl group, due to an amide bond formed between the carboxyl and amino groups in the presence of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC). Factors that can influence the binding of single stranded DNA to the carboxyl group are pH and ionic strength. The pH determines how many protons are available to form covalent bonds, with less being present as the pH gets higher. This results in less strands of DNA binding to each quantum dot. Lower ionic strength results more stable quantum dots, but also causes DNA strands to repel each other. Optimum coupling conditions for over 10 DNA strands per quantum dot are at a pH of 7 and an ionic strength of 0M. A neutral pH of 7 allows enough protons from the carboxyl group to facilitate covalent bonding of amino modified DNA, but not enough protons to destabilize the colloids
The addition of DNA to the surface of a quantum dot changes the intermolecular forces that occur between un-conjugated quantum dots. Changing the intermolecular forces between the quantum dots can alter many characteristics important for the use of quantum dots in aqueous conditions. As the surface of quantum dots are conjugated with DNA, the colloidal stability and solubility are affected.
Quantum dots conjugated with DNA are subject to electrostatic repulsion and Van der Waals forces which affect the colloidal stability of the quantum dot-DNA conjugates. Binding DNA to the surface of a quantum dot increases the stability of the quantum dots. The DNA chains provide more electrostatic repulsion than the surface of the quantum dots, which prevents them from aggregating and falling out of solution. The colloidal stability is estimated from the total interaction energy between two particles which calculated by the DLVO equation
- is separation between two particles
- is the radius of the particles
- is the permittivity of water
- is the surface potential
- is the inverse Debye length
VvdW is the attractive force between all particles. The Van der Waals forces are calculated with the equation
- is the effective Hamaker constant
The colloidal stability of the quantum dots can differ with changing pH and ionic strength. Overall, the DNA conjugation increases the stability of the quantum dots by providing electrostatic and steric repulsion, which prevents the particles from aggregating due to van der Waals forces.
In order to use quantum dots in many biology related applications, the quantum dots must be soluble in aqueous environments. For quantum dots to be solubilized in water, the amphiphilic ligands must be on the surface of quantum dots. DNA can be used as a solubilization ligand due to its amphiphilic nature. This allows quantum dots functionalized with DNA to be used in the aqueous conditions often found in biology and medical research. The increased solubility is necessary in order to allow quantum dots to be used as a DNA imaging probe in a biological system.
Quantum dots have become powerful imaging tools and are continually evolving for biocompatibility in the hopes of successfully imaging humans and other live biological systems. By reducing the amount of Cd released around cells, researchers have been striving to create in vitro and in vivo testing methods for imaging nano- and micro-scaled structures. The high resolution within the nanometer range demonstrates the usefulness for imaging DNA behavior for both bioengineering feedback and biological and chemical observation and analysis. The ability to control the emission spectra by altering the size of the quantum dots allows researchers to code many different targets by color.
|Size (nm)||Emission Peak (nm)||Color|
|7.3 ||655||dark red|
Quantifying and imaging gene expression
Since quantum dots have high photostability and luminescence, researchers are using them to light up mRNA within cells to image gene expression. Amine-modified oligonucleotide probes attached to carboxyl groups on quantum dots show sequence-specific hybridization. These probes can also detect low expressing genes. This potentially allows researchers to understand when and where certain proteins are made.
Self-assembled quantum dots form spontaneously under specific conditions during molecular beam epitaxy or another form of atomic deposition. This spontaneous formation is a consequence of the lattice-mismatch between the deposited semiconductor material and the underlying substrate. The resulting structure formed on the substrate surface is a three-dimensional "island" nanostructure. The islands are formed into quantum dots by covering them with another semiconductor material, in a process called quantum confinement. Self-Assembled quantum dots provide opportunities in technological applications such as quantum cryptography, quantum computing, optics and optoelectronics.
In the past, green fluorescent protein (GFP) was used to track movement inside cells. However, GFP does not light up well and is unstable after application. Thus, GFP prevented long term studies of protein movement. By using quantum dots, which are more stable, researchers can now track proteins through cells undergoing different pathways. In order to overcome the inability for the cameras to capture depth, researchers have developed a 3D tracking apparatus that can accurately map the path of proteins inside cells.
Live-time protein tracking
Because quantum dots have fine-tuned wavelength spectrums along with high emission intensities and small size, quantum dots have become the norm for molecule tracking. However, quantum dots have two levels: bright and dark. For low quantities, this is a problem as researchers need to retrace where the molecule went during the dark stage, which can vary from several milliseconds to hours. The blinking phenomenon is not a problem when imaging larger objects (i.e. tumors) as there will be enough quantum dots in the bright state to image, even while several may remain in their dark stage.
- X. Michalet; F. F. Pinaud; L. A. Bentolila; et al. (2005). "Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics". Science. 307 (5709): 538–544. Bibcode:2005Sci...307..538M. doi:10.1126/science.1104274. PMC 1201471. PMID 15681376.
- Catherine J. Murphy; Eric B. Brauns; Latha Gearheart (1996). "Quantum Dots as Inorganic DNA-Binding Proteins". MRS Proceedings. 452: 452–597. doi:10.1557/PROC-452-597.
- Santos, Ana R.; Miguel, Ana S.; Macovei, Anca. (2013). "CdSe/ZnS Quantum Dots trigger DNA repair and antioxidant enzyme systems in Medicago sativa cells in suspension culture". BMC Biotechnology. 13: 111. doi:10.1186/1472-6750-13-111. PMC 3901376. PMID 24359290.
- Gao, Xiaohu (2004). "In Vivo Cancer Targeting and Imaging with Semiconductor Quantum Dots". Nature Biotechnology. 22 (8): 969–976. doi:10.1038/nbt994. PMID 15258594.
- Pong, Boon Kin; Trout, Bernhardt L.; Lee, Jim Yang (2007). "Preparation of DNA-functionalized CdSe/ZnS Quantum Dots". Chemical and Pharmaceutical Engineering. 1.
- Dazhi Sun; Oleg Gang (2013). "DNA-Functionalized Quantum Dots: Fabrication, Structural, and Physicochemical Properties". Langmuir. 29 (23): 7038–7046. doi:10.1021/la4000186. PMID 23706124.
- Russel, W. B. (1989). Colloidal Dispersions. Cambridge University Press. ISBN 9780511608810.
- Mingyong Han; Xiaohu Gao; Jack Z. Su (2001). "Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules". Nature Biotechnology. 19 (7): 631–635. doi:10.1038/90228. PMID 11433273.
- Andrew M. Smith; Hongwei Duan; Aaron M. Mohs (2008). "Bioconjugated quantum dots for in vivo molecular and cellular imaging". Drug Delivery. 60 (11): 1226–1240. doi:10.1016/j.addr.2008.03.015. PMC 2649798. PMID 18495291.
- Daniele Gerion; Fabien Pinaud; Shara C. Williams (2001). "Synthesis and Properties of Biocompatible Water-Soluble Silica-Coated CdSe/ZnS Semiconductor Quantum Dots". J. Phys. Chem. B. 105 (37): 8861–8871. doi:10.1021/jp0105488.
- Warren CW Chan; Dustin J Maxwell; Xiaohu Gao (2002). "Luminescent quantum dots for multiplexed biological detection and imaging". Current Opinion in Biotechnology. 13 (1): 40–46. doi:10.1016/S0958-1669(02)00282-3. PMID 11849956.
- Choi, Youngseon; Kim, Hwa Pyung; Hong, Suk Min; Ryu, Ji Young; Han, Sung Jun; Song, Rita (18 September 2009). "In situ Visualization of Gene Expression Using Polymer-Coated Quantum-Dot-DNA Conjugates". Small. 5 (18): 2085–2091. doi:10.1002/smll.200900116. PMID 19517489.
- Ryman-Rasmussen, Jessica P; Riviere, Jim E; Monteiro-Riviere, Nancy A (10 August 2006). "Surface Coatings Determine Cytotoxicity and Irritation Potential of Quantum Dot Nanoparticles in Epidermal Keratinocytes". Journal of Investigative Dermatology. 127 (1): 143–153. doi:10.1038/sj.jid.5700508. PMID 16902417.
- Petroff, Pierre M.; Lorke, Axel; Imamoglu, Atac (May 2001). "Epitaxially Self-Assembled Quantum Dots" (5). Scitation. doi:10.1063/1.1381102.
- Baba, Koichi; Nishida, Kohji (2012). "Single-Molecule Tracking in Living Cells Using Single Quantum Dot Applications". Theranostics. 2 (7): 655–667. doi:10.7150/thno.3890. PMC 3418928. PMID 22896768.
- Wells, Nathan P.; Lessard, Guillaume A.; Goodwin, Peter M.; Phipps, Mary E.; Cutler, Patrick J.; Lidke, Diane S.; Wilson, Bridget S.; Werner, James H. (10 November 2010). "Time-Resolved Three-Dimensional Molecular Tracking in Live Cells". Nano Letters. 10 (11): 4732–4737. Bibcode:2010NanoL..10.4732W. doi:10.1021/nl103247v. PMC 3061257. PMID 20957984.
- Pinaud, Fabien; Clarke, Samuel; Sittner, Assa; Dahan, Maxime (30 March 2010). "Probing cellular events, one quantum dot at a time". Nature Methods. 7 (4): 275–285. doi:10.1038/NMETH.1444. PMID 20354518.